Sorry, it was "obscene offer": I'll sell the company when I get an obscene offer, and so far the offers we've received have been nowhere near obscene, http://ww2.gazette.net/stories/02082011/businew192334_32552.php Keep in mind the revenue in 2011 was $1.176M (http://www.otcmarkets.com/financialReportViewer?symbol=BIEL&id=76966) vs. $665k in 2013 (http://www.otcmarkets.com/financialReportViewer?symbol=BIEL&id=118081) where at both times FDA decisions that would benefit the company were "close". That's if you are assuming that FDA clearance happens this year. If I'm thinking of a buyout, why would I offer more than the "nowhere near obscene" offers that were made back in 2011? Similar rumors years ago too (O/S around 1.3B to 1.4B): http://investorshub.advfn.com/boards/read_msg.aspx?message_id=44302205